KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitReceivables - NetReceivables Refunds
Ratios

Takeda Pharmaceutical (TAK) Receivables - Net (2018 - 2026)

Takeda Pharmaceutical has reported Receivables - Net over the past 9 years, most recently at $5.4 billion for Q1 2026.

  • For Q1 2026, Receivables - Net rose 15.77% year-over-year to $5.4 billion; the TTM value through Mar 2026 reached $5.4 billion, up 15.77%, while the annual FY2026 figure was $5.6 billion, 20.43% up from the prior year.
  • Receivables - Net was $5.4 billion for Q1 2026 at Takeda Pharmaceutical, up from $4.7 billion in the prior quarter.
  • Across five years, Receivables - Net topped out at $5.4 billion in Q1 2026 and bottomed at -$80.8 million in Q1 2022.
  • The 5-year median for Receivables - Net is $4.5 billion (2024), against an average of $2.9 billion.
  • Year-over-year, Receivables - Net plummeted 101.09% in 2022 and then surged 14907.59% in 2024.
  • Over 5 years, Receivables - Net stood at -$80.8 million in 2022, then surged by 62.3% to -$30.5 million in 2023, then surged by 14907.59% to $4.5 billion in 2024, then increased by 3.1% to $4.7 billion in 2025, then grew by 15.77% to $5.4 billion in 2026.
  • The last three reported values for Receivables - Net were $5.4 billion (Q1 2026), $4.7 billion (Q1 2025), and $4.5 billion (Q1 2024) per Business Quant data.